Suppr超能文献

2419 例经组织学证实的良、恶性乳腺病变中细针抽吸的确定性。

Conclusiveness of fine needle aspiration in 2419 histologically confirmed benign and malignant breast lesions.

机构信息

Department of Surgery, Canisius Wilhelmina Ziekenhuis, Weg door Jonkerbosch 100, Nijmegen, The Netherlands.

出版信息

Breast. 2011 Jun;20(3):229-32. doi: 10.1016/j.breast.2011.01.002. Epub 2011 Jan 28.

Abstract

We aimed to retrospectively assess (1) the conclusiveness of breast fine needle aspiration (FNA) in a histologically confirmed population and (2) the clinical and radiologic determinants of a conclusive diagnosis. Aspirates were diagnosed as inadequate, benign, atypical, suspicious or malignant. We defined a conclusive FNA diagnosis as 'benign' in histologically benign lesions and as 'malignant' in histologically malignant lesions. In 2419 breast lesions, the proportion of conclusive diagnoses was 46.1% (95% confidence interval, 42.0-50.2%) in histologically benign lesions (n = 571) and 81.6% (95% confidence interval, 79.8%-83.4%) in histologically malignant lesions (n = 1848). On multivariate analysis, factors associated with a conclusive preoperative diagnosis included tumour diameter of 2-2.9 cm (P < 0.001), malignant histology (P < 0.001) and the pathologist examining the aspirate (P = 0.02). Breast FNA has to be utilised selectively in the routine work-up of breast lesions. In suspicious lesions of large size, FNA may still be used to obtain a quick confirmation of malignancy.

摘要

我们旨在回顾性评估

(1) 在组织学确诊的人群中,乳腺细针穿刺(FNA)的结论性;(2) 诊断明确的临床和影像学决定因素。穿刺标本的诊断为不充分、良性、非典型、可疑或恶性。我们将明确的 FNA 诊断定义为:组织学良性病变中的“良性”,组织学恶性病变中的“恶性”。在 2419 个乳腺病变中,组织学良性病变(n=571)的明确诊断比例为 46.1%(95%置信区间,42.0-50.2%),组织学恶性病变(n=1848)的明确诊断比例为 81.6%(95%置信区间,79.8%-83.4%)。多变量分析显示,与明确术前诊断相关的因素包括肿瘤直径 2-2.9cm(P<0.001)、恶性组织学(P<0.001)和检查穿刺标本的病理学家(P=0.02)。乳腺 FNA 在乳腺病变的常规检查中必须有选择性地使用。在大尺寸的可疑病变中,FNA 仍可用于快速确认恶性肿瘤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验